Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

AcuCort

0.68 SEK

-6.58 %

Less than 1K followers

ACUC

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for AcuCort

2019202020212022202320242025
Revenue0.70.7
growth-%1.5 %
EBITDA-8.4-7.7-11.3-14.8-13.3-17.4-18.3
EBIT-8.4-7.7-11.3-14.8-13.3-17.4-26.5
Profit before taxes-8.4-7.8-11.3-14.8-13.7-17.4-26.2
Net income-8.4-7.8-11.3-14.8-13.7-17.4-26.2
EPS-0.27-0.25-0.39-0.32-0.37-0.18-0.22
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-2,557.4 %-2,658.0 %
EBIT-%-2,557.4 %-3,839.1 %
ROE-15.5 %-16.8 %-18.8 %-32.4 %-28.8 %-42.6 %-41.1 %
ROI-14.9 %-16.4 %-17.9 %-29.8 %-23.4 %-38.4 %-39.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.